Cybersecurity expert: 5 things physicians should consider to help protect data

May 22, 2017
In this guest commentary, Zuly Gonzalez, co-founder and CEO of Light Point Security and former cybersecurity expert at the National Security

Q&A: Why health care remains a target to cyberattacks like WannaCry

May 22, 2017
Earlier this month, hackers executed a worldwide ransomware attack that has impacted more than 100 countries and infected tens of thousands of…
Meeting News

Bempedoic acid may further reduce LDL when added to high-intensity statin therapy

May 22, 2017
PHILADELPHIA — Patients treated with bempedoic acid in addition to high-intensity statin therapy had a reduction in LDL, according to results…
In the Journals

Successful CTO PCI linked to decreased mortality, CABG risk

May 22, 2017
Recently published data demonstrated a high success rate of elective chronic total occlusion PCI as well as an association between successful…
Meeting News

Experts highlight important literature in lipidology

May 22, 2017
PHILADELPHIA — Nutrition, gene variants and familial hypercholesterolemia were the topics of three important journal articles discussed at the…
In the Journals

Statins yielded no benefit for primary cardiovascular prevention in older adults

May 22, 2017
Among patients aged 65 years and older, there was no difference in all-cause mortality or cardiovascular outcomes between pravastatin and usual care…
Meeting NewsVideo

VIDEO: New NLA president discusses updates to PCSK9 inhibitor recommendations

May 22, 2017
PHILADELPHIA — In this Cardiology Today video exclusive, James A. Underberg, MD, MS, FACPM, FACP, FNLA, new president of the National Lipid…
Meeting NewsPerspective

Novel endovascular balloon may decrease mortality in superior vena cava tears

May 22, 2017
CHICAGO — A novel compliant endovascular balloon may have the potential to save lives in patients who experience superior vena cava tears…

ARCH study: Romosozumab data show increased cardiovascular risk

May 22, 2017
Treatment with the anti-sclerostin monoclonal antibody romosozumab resulted in fewer new fractures in postmenopausal women with high-risk…
In the Journals

Respiratory infections linked to nearly 20-fold increased risk for myocardial infarction

May 22, 2017
The risk for myocardial infarction is 17 times higher in the 7 days following a respiratory infection, according to research recently published in…
FDA News

FDA approves Actemra for giant cell arteritis

May 22, 2017
The FDA has approved Actemra for the treatment of adults with giant cell arteritis. “Rheumatologists will finally have available an option for…
Meeting News

Recent trials advance lipidology knowledge base

May 21, 2017
PHILADELPHIA — Numerous important trials in clinical lipidology have been reported over the last year, according to a presentation at the…
Meeting News

Diagnosis of Fredrickson-Levy-Lees dyslipidemias inconsistent

May 21, 2017
PHILADELPHIA — A variance in the two qualitative approaches to diagnose patients with Fredrickson-Levy-Lees dyslipidemias may explain the…
Meeting News

FOURIER: Evolocumab reduces CV events regardless of baseline LDL, statin intensity

May 21, 2017
PHILADELPHIA — A subanalysis of the FOURIER trial presented at the National Lipid Association Scientific Sessions found that evolocumab was…
Meeting News

PCSK9 inhibition reduces LDL in patients on top of other therapies

May 21, 2017
PHILADELPHIA — In a real-world cohort of patients on maximally tolerated lipid-lowering therapies, PCSK9 inhibitors lowered LDL by 26% to 52%…
Meeting News

PCSK9 inhibitors recommended by NLA for certain patient groups

May 20, 2017
PHILADELPHIA — A National Lipid Association expert panel prepared updated recommendations for the use of PCSK9 antibody therapy at the NLA
Meeting News

Multiple factors help predict risk for patients with FH

May 20, 2017
PHILADELPHIA — LDL is not the sole predictor of CVD in the familial hypercholesterolemia patient population, according to a presentation at
Meeting News

LDL lowering more robust in men vs. women in concomitant PCSK9 inhibitor, statin therapy

May 20, 2017
PHILADELPHIA — In a small cohort of patients taking PSCK9 inhibitors, men had a lower reduction in LDL than women among those also on statin
Meeting News

PCSK9 inhibitor studies show benefit for patients with high LDL

May 20, 2017
PHILADELPHIA — Numerous studies on PCSK9 inhibitors have been completed that establish their efficacy and safety in patients with high LDL
Meeting News

Performance of CETP inhibitors vexing

May 20, 2017
PHILADELPHIA — While cholesterol ester transfer protein inhibitors raise HDL and some lower LDL, they have so far not shown any impact on CV
Advertisement
Advertisement